Acute severe asthma - World Allergy Organization
... • Maintain normal activity levels, including exercise • Maintain pulmonary function as close to normal levels as possible • Prevent asthma exacerbations • Avoid adverse effects from asthma medications • Prevent asthma mortality ...
... • Maintain normal activity levels, including exercise • Maintain pulmonary function as close to normal levels as possible • Prevent asthma exacerbations • Avoid adverse effects from asthma medications • Prevent asthma mortality ...
guidelines for the screening, care and treatment of persons with
... Health Organization (WHO) issued its first Guidelines for the screening, care and treatment of persons with hepatitis C infection in 2014, several new medicines have been approved by at least one stringent regulatory authority. These medicines, called direct-acting antivirals (DAAs), are transformin ...
... Health Organization (WHO) issued its first Guidelines for the screening, care and treatment of persons with hepatitis C infection in 2014, several new medicines have been approved by at least one stringent regulatory authority. These medicines, called direct-acting antivirals (DAAs), are transformin ...
Concise Review
... maintenance therapy with prolongation of remission. Alpha interferon also shown again to have some benefit in prolonging remission. ...
... maintenance therapy with prolongation of remission. Alpha interferon also shown again to have some benefit in prolonging remission. ...
Latanoprostene Bunod, a Dual-acting Nitric Oxide Donating
... urrent topical treatments for glaucoma have limited efficacy in lowering intraocular pressure (IOP) and/or can produce side effects and tolerability problems. At present, IOP remains the only known modifiable risk factor to delay the progression of glaucoma. The novel IOP-lowering treatment latanopr ...
... urrent topical treatments for glaucoma have limited efficacy in lowering intraocular pressure (IOP) and/or can produce side effects and tolerability problems. At present, IOP remains the only known modifiable risk factor to delay the progression of glaucoma. The novel IOP-lowering treatment latanopr ...
Recommendations for management of common childhood conditions
... Clinical care at first-referral hospitals in low-income countries is often provided by nurses, paramedical workers, and non-specialist general doctors with very limited resources. There is often inadequate support from the central level, poor access to information, little ongoing professional develo ...
... Clinical care at first-referral hospitals in low-income countries is often provided by nurses, paramedical workers, and non-specialist general doctors with very limited resources. There is often inadequate support from the central level, poor access to information, little ongoing professional develo ...
Preview the material
... leads to problems with concentration or memory, as well as a feeling of being distracted, sometimes referred to as the fibro fog. Depression is present in approximately 30 percent of cases, and it often coincides with anxiety.26 Unfortunately, people suffering from depression, whether or not they cu ...
... leads to problems with concentration or memory, as well as a feeling of being distracted, sometimes referred to as the fibro fog. Depression is present in approximately 30 percent of cases, and it often coincides with anxiety.26 Unfortunately, people suffering from depression, whether or not they cu ...
Product Information - Therapeutic Goods Administration
... Humira was evaluated in over 3000 patients in all rheumatoid arthritis clinical trials. Some patients were treated for greater than 60 months duration. The efficacy and safety of Humira were assessed in five randomised, double-blind and well-controlled studies. The primary efficacy endpoint in those ...
... Humira was evaluated in over 3000 patients in all rheumatoid arthritis clinical trials. Some patients were treated for greater than 60 months duration. The efficacy and safety of Humira were assessed in five randomised, double-blind and well-controlled studies. The primary efficacy endpoint in those ...
NACCT 2014, New Orleans LA
... Background: Ondansetron is a commonly used antiemetic that has been linked to QT interval prolongation. Prolongation of the QT interval may result in tachyarrhythmias, including torsades de pointes, potentially placing patients at risk for sudden cardiac death. To date, it is not clear whether ondan ...
... Background: Ondansetron is a commonly used antiemetic that has been linked to QT interval prolongation. Prolongation of the QT interval may result in tachyarrhythmias, including torsades de pointes, potentially placing patients at risk for sudden cardiac death. To date, it is not clear whether ondan ...
PDF - The Asia-Pacific Journal of Ophthalmology
... Liu et al34 measured IOP every 2 hours in the sitting and supine positions during the waking period and in the supine position during the sleeping period throughout a 24-hour period in patients with newly diagnosed glaucoma and healthy control subjects. They determined that, when in physiologic posi ...
... Liu et al34 measured IOP every 2 hours in the sitting and supine positions during the waking period and in the supine position during the sleeping period throughout a 24-hour period in patients with newly diagnosed glaucoma and healthy control subjects. They determined that, when in physiologic posi ...
Acid-Base and Electrolyte Teaching Case Approach to Treatment of Hypophosphatemia
... Hypophosphatemia can be acute or chronic. Acute hypophosphatemia with phosphate depletion is common in the hospital setting and results in significant morbidity and mortality. Chronic hypophosphatemia, often associated with genetic or acquired renal phosphate-wasting disorders, usually produces abno ...
... Hypophosphatemia can be acute or chronic. Acute hypophosphatemia with phosphate depletion is common in the hospital setting and results in significant morbidity and mortality. Chronic hypophosphatemia, often associated with genetic or acquired renal phosphate-wasting disorders, usually produces abno ...
A new perspective on concepts of asthma severity and control PERSPECTIVE
... corticosteroids in all patients who fail to achieve optimal control on lower doses. Therefore, such patients were unable to be classified under this system. An expanded approach to defining severity was taken in the 2002 GINA guidelines (table 4) [7]. The initial assessment of severity (and hence th ...
... corticosteroids in all patients who fail to achieve optimal control on lower doses. Therefore, such patients were unable to be classified under this system. An expanded approach to defining severity was taken in the 2002 GINA guidelines (table 4) [7]. The initial assessment of severity (and hence th ...
Describing self-care in Italian adults with heart failure and identifying
... whom were nurses. Participants, recruited between January 2011 and November 2012, were invited to participate if they had a diagnosis of HF confirmed by echocardiogram and clinical evidence of HF (i.e. with signs and symptoms ...
... whom were nurses. Participants, recruited between January 2011 and November 2012, were invited to participate if they had a diagnosis of HF confirmed by echocardiogram and clinical evidence of HF (i.e. with signs and symptoms ...
Describing self-care in Italian adults with heart failure and identifying
... whom were nurses. Participants, recruited between January 2011 and November 2012, were invited to participate if they had a diagnosis of HF confirmed by echocardiogram and clinical evidence of HF (i.e. with signs and symptoms ...
... whom were nurses. Participants, recruited between January 2011 and November 2012, were invited to participate if they had a diagnosis of HF confirmed by echocardiogram and clinical evidence of HF (i.e. with signs and symptoms ...
Handout on Health: Systemic Lupus Erythematosus
... those in which significant and potentially fatal damage occurs to vital organs such as the lungs, heart, kidney, and brain. The disease is characterized by “flares” of activity interspersed with periods of improvement or remission. A flare, or exacerbation, is increased activity of the disease proce ...
... those in which significant and potentially fatal damage occurs to vital organs such as the lungs, heart, kidney, and brain. The disease is characterized by “flares” of activity interspersed with periods of improvement or remission. A flare, or exacerbation, is increased activity of the disease proce ...
ari - Cardiosource
... A recommendation with Level of Evidence B or C does not imply that the recommendation is weak. Many important clinical questions addressed in the guidelines do not lend themselves to clinical trials. Although randomized trials are unavailable, there may be a very clear clinical consensus that a part ...
... A recommendation with Level of Evidence B or C does not imply that the recommendation is weak. Many important clinical questions addressed in the guidelines do not lend themselves to clinical trials. Although randomized trials are unavailable, there may be a very clear clinical consensus that a part ...
Guidelines for Diagnosis, Treatment, and Prevention
... 18. Surgical consult should be obtained in all patients with complicated CDI. Surgical therapy should be considered in patients with any one of the following attributed to CDI: hypotension requiring vasopressor therapy; clinical signs of sepsis and organ dysfunction (renal and pulmonary); mental sta ...
... 18. Surgical consult should be obtained in all patients with complicated CDI. Surgical therapy should be considered in patients with any one of the following attributed to CDI: hypotension requiring vasopressor therapy; clinical signs of sepsis and organ dysfunction (renal and pulmonary); mental sta ...
What Does Diagnosis of Endometriosis Mean? The Patient`s
... Symptoms associated with endometriosis negatively impact the patient’s quality of life both personally and professionally. As stated previously, reoccurrence of disease in patients receiving treatment for endometriosis can be as high as 50% in as little as one year after stopping treatment or surgic ...
... Symptoms associated with endometriosis negatively impact the patient’s quality of life both personally and professionally. As stated previously, reoccurrence of disease in patients receiving treatment for endometriosis can be as high as 50% in as little as one year after stopping treatment or surgic ...
Guidelines for Diagnosis, Treatment, and Prevention of Clostridium
... 18. Surgical consult should be obtained in all patients with complicated CDI. Surgical therapy should be considered in patients with any one of the following attributed to CDI: hypotension requiring vasopressor therapy; clinical signs of sepsis and organ dysfunction (renal and pulmonary); mental sta ...
... 18. Surgical consult should be obtained in all patients with complicated CDI. Surgical therapy should be considered in patients with any one of the following attributed to CDI: hypotension requiring vasopressor therapy; clinical signs of sepsis and organ dysfunction (renal and pulmonary); mental sta ...
1. PACKAGE INSERT OXYCONTIN® (OXYCODONE HCl
... Studies in normal volunteers and patients reveal predictable relationships between oxycodone dosage and plasma oxycodone concentrations, as well as between concentration and certain expected opioid effects, such as pupillary constriction, sedation, overall “drug effect”, analgesia and feelings of “r ...
... Studies in normal volunteers and patients reveal predictable relationships between oxycodone dosage and plasma oxycodone concentrations, as well as between concentration and certain expected opioid effects, such as pupillary constriction, sedation, overall “drug effect”, analgesia and feelings of “r ...
Guidelines for the Diagnosis and Management of Asthma–Summary Report 2007
... Highlights of the National Asthma Education and Prevention Program’s Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma–Full Report 2007 are presented in this EPR-3 summary report. The updated guidelines emphasize the importance of asthma control. Asthma control is ...
... Highlights of the National Asthma Education and Prevention Program’s Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma–Full Report 2007 are presented in this EPR-3 summary report. The updated guidelines emphasize the importance of asthma control. Asthma control is ...
Creutzfeldt-Jakob Disease (CJD) Risk Assessment and
... Routine containment and cleaning procedures should be used for the whole operating room, including surfaces, unless a spill of higher-infectivity tissue has occurred. Spill-Kits containing either 20,000ppm (free chlorine) sodium hypochlorite or 1M sodium hydroxide (NAOH) are to be available in areas ...
... Routine containment and cleaning procedures should be used for the whole operating room, including surfaces, unless a spill of higher-infectivity tissue has occurred. Spill-Kits containing either 20,000ppm (free chlorine) sodium hypochlorite or 1M sodium hydroxide (NAOH) are to be available in areas ...
product monograph - Takeda Canada Inc.
... Adverse events have been recorded during controlled clinical investigations in over 13,000 patients exposed to pantoprazole sodium as the single therapeutic agent for treatment of conditions requiring acid suppression. The following adverse reactions considered possibly, probably, or definitely rela ...
... Adverse events have been recorded during controlled clinical investigations in over 13,000 patients exposed to pantoprazole sodium as the single therapeutic agent for treatment of conditions requiring acid suppression. The following adverse reactions considered possibly, probably, or definitely rela ...
J Medical Treatment of Juvenile Idiopathic Arthritis CLINICAL REVIEW
... reclassification, is the most common rheumatic disease of childhood.1 JIA is defined as persistent arthritis for more than 6 weeks with an onset at less than 16 years of age, after excluding other causes. JIA consists of several subtypes (TABLE 1, FIGURE 1).2,3 Recent data show that most children ne ...
... reclassification, is the most common rheumatic disease of childhood.1 JIA is defined as persistent arthritis for more than 6 weeks with an onset at less than 16 years of age, after excluding other causes. JIA consists of several subtypes (TABLE 1, FIGURE 1).2,3 Recent data show that most children ne ...
Surviving Sepsis Campaign: International Guidelines for
... and that most clinicians should use it in most situations. Circumstances may exist in which a strong recommendation cannot or should not be followed for an individual because of that patient’s preferences or clinical characteristics that make the recommendation less applicable. These are described i ...
... and that most clinicians should use it in most situations. Circumstances may exist in which a strong recommendation cannot or should not be followed for an individual because of that patient’s preferences or clinical characteristics that make the recommendation less applicable. These are described i ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.